|
Volumn 24, Issue 8, 2005, Pages 1150-1154
|
First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure
a a a a a a a c c c a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADRENALIN;
APROTININ;
DOBUTAMINE;
FLUCONAZOLE;
GLYCERYL TRINITRATE;
HEPARIN;
INOTROPIC AGENT;
IRBESARTAN;
MEROPENEM;
NITROPRUSSIDE SODIUM;
NORADRENALIN;
VANCOMYCIN;
WARFARIN;
AGED;
AORTA VALVE REGURGITATION;
ARTICLE;
BRAIN EMBOLISM;
BRAIN INFARCTION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONGESTIVE HEART FAILURE;
DEVICE INFECTION;
HEART ATRIUM SEPTUM DEFECT;
HEART LEFT VENTRICLE FAILURE;
HEART VENTRICLE THROMBOSIS;
HUMAN;
HYPERTENSION;
IMPLANT;
MALE;
POSTOPERATIVE HEMORRHAGE;
POSTOPERATIVE INFECTION;
POSTOPERATIVE THROMBOSIS;
PRIORITY JOURNAL;
THROMBOEMBOLISM;
TRANSESOPHAGEAL ECHOCARDIOGRAPHY;
AGED;
CARDIOMYOPATHY, DILATED;
EQUIPMENT DESIGN;
EQUIPMENT SAFETY;
FOLLOW-UP STUDIES;
HEART FAILURE, CONGESTIVE;
HEART VENTRICLES;
HEART-ASSIST DEVICES;
HUMANS;
MALE;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TOMOGRAPHY, X-RAY COMPUTED;
TREATMENT OUTCOME;
VENTRICULAR DYSFUNCTION, LEFT;
|
EID: 23744469834
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: 10.1016/j.healun.2005.01.014 Document Type: Article |
Times cited : (41)
|
References (10)
|